Kazal Type Serine Protease Inhibitor Domain Containing Protein 1 (KAZALD1)

BONO1; FKSG28; FKSG40

SPN	M748
HGNC	25460
MGI	2147606
PubMed	12975309
RGD	1310698
UniProt	Q96I82
Wiki	KAZALD1

KAZALD1 encodes a secreted member of the insulin growth factor-binding protein (IGFBP) superfamily. It contains an N-terminal insulin growth factor-binding domain, a central Kazal-type serine protease inhibitor and follistatin-like domain, and a C-terminal immunoglobulin-like domain. Studies of the mouse ortholog suggest that this gene product may have a function in bone development and bone regeneration.

Bmp2 increased expression of Kazald1 in mouse myoblast, osteoblastic, and mesenchymal stem cell lines, and in primary murine osteoblastic cells. Addition of recombinant Kazald1 promoted proliferation but not differentiation of osteoblastic cells.

Reference

"The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment."
Genome Res. 13:2265-2270(2003) [PubMed] [Europe PMC] [Abstract]

"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]

"The DNA sequence and comparative analysis of human chromosome 10."
Nature 429:375-381(2004) [PubMed] [Europe PMC] [Abstract]

"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]

"Signal peptide prediction based on analysis of experimentally verified cleavage sites."
Protein Sci. 13:2819-2824(2004) [PubMed] [Europe PMC] [Abstract]